Donnatal is an adjunctive therapy used in the treatment of irritable bowel syndrome and acute enterocolitis. Irritable Bowel Syndrome, which affects over 35 million people, is a chronic, often debilitating, functional gastrointestinal disorder with symptoms that include abdominal pain, bloating and altered bowel behaviors.

PBM purchased the Donnatal brand from Wyeth in 2002, operated the business and grew the brand from $2 million in sales to over $50 million. In 2014, we sold the business to Concordia (TOR:CRX).


Purchased from Wyeth
PBM Operated 2002
Acquired 2014